Minnesota HF 4266: Prescription drug benefit transparency and disclosure required.

Status: Introduction and first reading, referred to Commerce Finance and Policy (as of 2022-03-14)

State: Minnesota · Session: 2021-2022 · Bill: HF 4266

Subjects: Drugs and Medicine, Health and Health Department

Sponsors: Lislegard

View Minnesota HF 4266 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.